Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.890
-0.019 (-2.12%)
At close: Dec 5, 2025, 4:00 PM EST
0.888
-0.002 (-0.22%)
After-hours: Dec 5, 2025, 8:00 PM EST
Kairos Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 19 | 20 | - | - | - |
| Enterprise Value | 13 | 16 | - | - | - |
| Last Close Price | 0.89 | 1.52 | - | - | - |
| PB Ratio | 2.42 | 4.09 | - | - | - |
| P/TBV Ratio | 2.45 | 4.29 | - | - | - |
| Debt / Equity Ratio | - | - | -0.31 | -0.50 | -0.34 |
| Quick Ratio | 13.87 | 1.28 | 0.04 | 0.27 | 0.04 |
| Current Ratio | 16.56 | 4.20 | 0.04 | 0.27 | 0.04 |
| Return on Equity (ROE) | -92.07% | -192.96% | - | - | - |
| Return on Assets (ROA) | -53.59% | -43.50% | -107.07% | -39.41% | - |
| Return on Capital (ROIC) | -62.88% | -87.69% | - | - | - |
| Return on Capital Employed (ROCE) | -73.10% | -49.10% | 119.00% | 95.60% | 166.50% |
| Earnings Yield | -27.32% | -13.33% | - | - | - |
| Buyback Yield / Dilution | -55.64% | -9.38% | -1.42% | -11.86% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.